全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...
PLOS ONE  2013 

Comparative Proteome Profile of Human Placenta from Normal and Preeclamptic Pregnancies

DOI: 10.1371/journal.pone.0078025

Full-Text   Cite this paper   Add to My Lib

Abstract:

To better understand the molecular mechanisms involved in pathological development of placenta in preeclampsia, we used LC-MS/MS to construct a large-scale comparative proteome profile of human placentas from normal and preeclamptic pregnancies. A total of 2636 proteins were detected in human placentas, and 171 different proteins were definitively identified between control and preeclamptic placentas. Further bioinformatics analysis indicated that these differentially expressed proteins correlate with several specific cellular processes which occur during pathological changes of preeclamptic placenta. 6 proteins were randomly selected to verify their expression patterns with Western blotting. Of which, 3 proteins’ cellular localizations were validated with immunohistochemistry. Elucidation of how protein-expression changes coordinate the pathological development would provide researchers with a better understanding of the critical biological processes of preeclampsia and potential targets for therapeutic agents to regulate placenta function, and eventually benefit the treatment of preeclampsia.

References

[1]  Redman CW, Sargent IL (2005) Latest advances in understanding preeclampsia. Science 308: 1592-1594. doi:10.1126/science.1111726. PubMed: 15947178.
[2]  Silasi M, Cohen B, Karumanchi SA, Rana S (2010) Abnormal placentation, angiogenic factors, and the pathogenesis of preeclampsia. Obstet Gynecol Clin North Am 37(2): 239-253. doi:10.1016/j.ogc.2010.02.013. PubMed: 20685551.
[3]  Duley L (2009) The global impact of preeclampsia and eclampsia. Semin Perinatol 33: 130-137. doi:10.1053/j.semperi.2009.02.010. PubMed: 19464502.
[4]  Walker JJ (2000) Pre-eclampsia. Lancet 356: 1260-1265. doi:10.1016/S0140-6736(00)02800-2. PubMed: 11072961.
[5]  Hiden U, Bilban M, Kn?fler M, Desoye G (2007) Kisspeptins and the placenta: regulation of trophoblast invasion. Rev Endocr Metab Disord 8: 31-39. doi:10.1007/s11154-007-9030-8. PubMed: 17351756.
[6]  Eastabrook G, Brown M, Sargent I (2011) The origins and end-organ consequence of pre-eclampsia. Best Pract Res Clin Obstet Gynaecol 25: 435-447. doi:10.1016/j.bpobgyn.2011.01.005. PubMed: 21367667.
[7]  Myatt L, Cui X (2004) Oxidative stress in the placenta. Histochem Cell Biol 122: 369-382. doi:10.1007/s00418-004-0677-x. PubMed: 15248072.
[8]  Brar HS, Platt LD, DeVore GR, Horenstein J, Medearis AL (1988) Qualitative assessment of maternal uterine and fetal umbilical artery blood flow and resistance in laboring patients by Doppler velocimetry. Am J Obstet Gynecol 158: 952-956. PubMed: 2966588.
[9]  Genbacev O, Joslin R, Damsky CH, Polliotti BM, Fisher SJ (1996) Hypoxia alters early gestation human cytotrophoblast differentiation/invasion in vitro and models the placental defects that occur in preeclampsia. J Clin Invest 97(2): 540-550. doi:10.1172/JCI118447. PubMed: 8567979.
[10]  Zhang Y, Zhao S, Gu Y, Lewis DF, Alexander JS, Wang Y (2005) Effects of peroxynitrite and superoxide radicals on endothelial monolayer permeability: potential role of peroxynitrite in preeclampsia. J Soc Gynecol Invest 12(8): 586-592. doi:10.1016/j.jsgi.2005.09.003. PubMed: 16325748.
[11]  Copland IB, Adamson SL, Post M, Lye SJ, Caniggia I (2002) TGF-beta 3 expression during umbilical cord development and its alteration in pre-eclampsia. Placenta 23(4): 311-321. doi:10.1053/plac.2001.0778. PubMed: 11969342.
[12]  Sundrani DP, Reddy US, Joshi AA, Mehendale SS, Chavan-Gautam PM et al. (2013) Differential placental methylation and expression of VEGF, FLT-1 and KDR genes in human term and preterm preeclampsia. Clin. Epigenetics 5(1): 6. doi:10.1186/1868-7083-5-6.
[13]  Sifakis S, Akolekar R, Kappou D, Mantas N, Nicolaides KH (2011) Maternal serum insulin-like growth factor-binding protein-1 (IGFBP-1) at 11-13 weeks in pre-eclampsia. Prenat Diag 31(2): 196-201. doi:10.1002/pd.2682. PubMed: 21268040.
[14]  Kauma SW, Bae-Jump V, Walsh SW (1999) Hepatocyte growth factor stimulates trophoblast invasion: a potential mechanism for abnormal placentation in preeclampsia. J Clin Endocrinol Metab 84(11): 4092-4096. doi:10.1210/jc.84.11.4092. PubMed: 10566655.
[15]  Bodova KB, Biringer K, Dokus K, Ivankova J, Stasko J, Danko J (2011) Fibronectin, plasminogen activator inhibitor type 1 (PAI-1) and uterine artery Doppler velocimetry as markers of preeclampsia. Dis Markers 30(4): 191-196. doi:10.1155/2011/219350. PubMed: 21694445.
[16]  Abdulsid A, Hanretty K, Lyall F (2013) Heat shock protein 70 expression is spatially distributed in human placenta and selectively upregulated during labor and preeclampsia. PLOS ONE 8(1): e54540. doi:10.1371/journal.pone.0054540. PubMed: 23382911.
[17]  Zhou P, Luo X, Qi HB, Zong WJ, Zhang H, Liu DD, Li QS (2012) The expression of pentraxin 3 and tumor necrosis factor-alpha is increased in preeclamptic placental tissue and maternal serum. Inflamm Res 61(9): 1005-1012. doi:10.1007/s00011-012-0507-x. PubMed: 22714118.
[18]  Schreurs MP, Hubel CA, Bernstein IM, Jeyabalan A, Cipolla MJ (2013) Increased oxidized low-density lipoprotein causes blood-brain barrier disruption in early-onset preeclampsia through LOX-1. FASEB J 27(3): 1254-1263. doi:10.1096/fj.12-222216. PubMed: 23230281.
[19]  Shen P, Gong Y, Wang T, Chen Y, Jia J et al. (2012) Expression of osteoprotegerin in placenta and its association with preeclampsia. PLOS ONE 7(8): e44340. doi:10.1371/journal.pone.0044340. PubMed: 22952959.
[20]  Qiao C, Wang C, Zhao J, Liu C, Shang T (2012) Elevated expression of KiSS-1 in placenta of Chinese women with early-onset preeclampsia. PLOS ONE 7(11): e48937. doi:10.1371/journal.pone.0048937. PubMed: 23145030.
[21]  Lewis DF, Canzoneri BJ, Gu Y, Zhao S, Wang Y (2010) Maternal levels of prostacyclin, thromboxane, ICAM, and VCAM in normal and preeclamptic pregnancies. Am J Reprod Immunol 64(6): 376-383. doi:10.1111/j.1600-0897.2010.00861.x. PubMed: 20482519.
[22]  Jurcovicová J, Krueger KS, Nandy I, Lewis DF, Brooks GG, Brown EG (1998) Expression of platelet-derived growth factor-A mRNA in human placenta: effect of magnesium infusion in pre-eclampsia. Placenta 19(5-6): 423-427. doi:10.1016/S0143-4004(98)90083-2. PubMed: 9699964.
[23]  Neudeck H, Joncic M, Schuster C, Bisson S, Hildebrandt R et al. (1997) Histochemical evaluation of placental dipeptidyl peptidase IV (CD26) in pre-eclampsia: enzyme activity in villous trophoblast indicates an enhanced likelihood of gestational hypertensive disorders. Am J Reprod Immunol 37(6): 449-458. doi:10.1111/j.1600-0897.1997.tb00259.x. PubMed: 9228301.
[24]  Causevic M, Mohaupt M (2007) 11 beta-Hydroxysteroid dehydrogenase type 2 in pregnancy and preeclampsia. Mol Aspects Med 28(2): 220-226. doi:10.1016/j.mam.2007.04.003. PubMed: 17532462.
[25]  Shin JK, Jeong YT, Jo HC, Kang MY, Chang IS et al. (2009) Increased interaction between heat shock protein 27 and mitogen-activated protein kinase (p38 and extracellular signal-regulated kinase) in pre-eclamptic placentas. J Obstet Gynaecol Res 35(5): 888-894. doi:10.1111/j.1447-0756.2009.01053.x. PubMed: 20149037.
[26]  Chen R, Tan Y, Wang M, Wang F, Yao Z et al. (2011) Development of glycoprotein capture-based label-free method for the high-throughput screening of differential glycoproteins in hepatocellular carcinoma. Mol Cell Proteomics 10(7): M110.006445. PubMed: 21474793.
[27]  Sun Z, Qin H, Wang F, Cheng K, Dong M et al. (2012) Capture and dimethyl labeling of glycopeptides on hydrazide beads for quantitative glycoproteomics analysis. Anal Chem 84(20): 8452-8456. doi:10.1021/ac302130r. PubMed: 23009578.
[28]  Sun Z, Chen R, Cheng K, Liu H, Qin H et al. (2012) A new method for quantitative analysis of cell surface glycoproteome. Proteomics 12(22): 3328-3337. doi:10.1002/pmic.201200150. PubMed: 23001842.
[29]  Xu B, Hua J, Zhang Y, Jiang X, Zhang H et al. (2011) Proliferating cell nuclear antigen (PCNA) regulates primordial follicle assembly by promoting apoptosis of oocytes in fetal and neonatal mouse ovaries. PLOS ONE 6(1): e16046. doi:10.1371/journal.pone.0016046. PubMed: 21253613.
[30]  Zhang Y, Xu B, Yang Y, Ban R, Zhang H et al. (2012) CPSS: a computational platform for the analysis of small RNA deep sequencing data. Bioinformatics 28(14): 1925-1927. doi:10.1093/bioinformatics/bts282. PubMed: 22576177.
[31]  Kaitu'u-Lino TJ, Palmer KR, Whitehead CL, Williams E, Lappas M, Tong S (2012) MMP-14 is expressed in preeclamptic placentas and mediates release of soluble endoglin. Am J Pathol 180(3): 888-8894. doi:10.1016/j.ajpath.2011.11.014. PubMed: 22296769.
[32]  Kaitu'u-Lino TJ, Tuohey L, Ye L, Palmer K, Skubisz M, Tong S (2013) MT-MMPs in pre-eclamptic placenta: relationship to soluble endoglin production. Placenta 34(2): 168-173. doi:10.1016/j.placenta.2012.11.034. PubMed: 23261267.
[33]  Liu C, Zhang N, Yu H, Chen Y, Liang Y et al. (2011) Proteomic analysis of human serum for finding pathogenic factors and potential biomarkers in preeclampsia. Placenta 32(2): 168-174. doi:10.1016/j.placenta.2010.11.007. PubMed: 21145106.
[34]  Kolla V, Jen? P, Moes S, Lapaire O, Hoesli I, Hahn S (2012) Quantitative proteomic (iTRAQ) analysis of 1st trimester maternal plasma samples in pregnancies at risk for preeclampsia. J Biomed Biotechnol, 2012: 305964. PubMed: 22570525.
[35]  Blumenstein M, McMaster MT, Black MA, Wu S, Prakash R et al. (2009) A proteomic approach identifies early pregnancy biomarkers for preeclampsia: novel linkages between a predisposition to preeclampsia and cardiovascular disease. Proteomics 9(11): 2929-2945. doi:10.1002/pmic.200800625. PubMed: 19444803.
[36]  Blankley RT, Robinson NJ, Aplin JD, Crocker IP, Gaskell SJ et al. (2010) A gel-free quantitative proteomics analysis of factors released from hypoxic-conditioned placentae. Reprod Sci 17(3): 247-257. doi:10.1177/1933719109351320. PubMed: 19907055.
[37]  Gharesi-Fard B, Zolghadri J, Kamali-Sarvestani E (2010) Proteome differences of placenta between pre-eclampsia and normal pregnancy. Placenta 31(2): 121-125. doi:10.1016/j.placenta.2009.11.004. PubMed: 19954843.
[38]  Epiney M, Ribaux P, Arboit P, Irion O, Cohen M (2012) Comparative analysis of secreted proteins from normal and preeclamptic trophoblastic cells using proteomic approaches. J Proteomics 75(6): 1771-1777. doi:10.1016/j.jprot.2011.12.021. PubMed: 22234358.
[39]  Johnstone ED, Sawicki G, Guilbert L, Winkler-Lowen B, Cadete VJ, Morrish DW (2011) Differential proteomic analysis of highly purified placental cytotrophoblasts in pre-eclampsia demonstrates a state of increased oxidative stress and reduced cytotrophoblast antioxidant defense. Proteomics 11(20): 4077-4084. doi:10.1002/pmic.201000505. PubMed: 21800423.
[40]  Carty DM, Siwy J, Brennand JE, Zürbig P, Mullen W et al. (2011) Urinary proteomics for prediction of preeclampsia. Hypertension 57(3): 561-569. doi:10.1161/HYPERTENSIONAHA.110.164285. PubMed: 21199994.
[41]  Shin JK, Baek JC, Kang MY, Park JK, Lee SA et al. (2011) Proteomic analysis reveals an elevated expression of heat shock protein 27 in preeclamptic placentas. Gynecol Obstet Invest 71(3): 151-157. doi:10.1159/000315162. PubMed: 21335933.
[42]  Genbacev O, DiFederico E, McMaster M, Fisher SJ (1999) Invasive cytotrophoblast apoptosis in pre-eclampsia. Hum Reprod 14(Suppl 2): 59-66. doi:10.1093/humrep/14.suppl_2.59. PubMed: 10690801.
[43]  DiFederico E, Genbacev O, Fisher SJ (1999) Preeclampsia is associated with widespread apoptosis of placental cytotrophoblasts within the uterine wall. Am J Pathol 155(1): 293-301. doi:10.1016/S0002-9440(10)65123-1. PubMed: 10393861.
[44]  Reister F, Frank HG, Kingdom JC, Heyl W, Kaufmann P et al. (2001) Macrophage-induced apoptosis limits endovascular trophoblast invasion in the uterine wall of preeclamptic women. Lab Invest 81(8): 1143-1152. doi:10.1038/labinvest.3780326. PubMed: 11502865.
[45]  Heazell AE, Brown M, Worton SA, Dunn WB (2011) The effects of oxygen on normal and pre-eclamptic placental tissue--insights from metabolomics. Placenta 32(Suppl 2): S119-S124. doi:10.1016/j.placenta.2010.12.001. PubMed: 21195475.
[46]  Gratacós E, Casals E, Deulofeu R, Gómez O, Cararach V et al. (1999) Serum and placental lipid peroxides in chronic hypertension during pregnancy with and without superimposed preeclampsia. Hypertens Pregnancy 18(2): 139-146. doi:10.3109/10641959909023073. PubMed: 10476615.
[47]  Gratacós E, Casals E, Deulofeu R, Cararach V, Alonso PL, Fortuny A (1998) Lipid peroxide and vitamin E patterns in pregnant women with different types of hypertension in pregnancy. Am J Obstet Gynecol 178(5): 1072-1076. doi:10.1016/S0002-9378(98)70550-2. PubMed: 9609586.
[48]  Zusterzeel PL, Rütten H, Roelofs HM, Peters WH, Steegers EA (2001) Protein carbonyls in decidua and placenta of pre-eclamptic women as markers for oxidative stress. Placenta 22(2-3): 213-219. doi:10.1053/plac.2000.0606. PubMed: 11170826.
[49]  Romanowicz L, Bańkowski E, Jaworski S (2000) Stimulation of glycosaminoglycan biosynthesis by umbilical cord serum of newborns delivered by mothers with EPH gestosis (preeclampsia). Pathobiology 68(6): 264-269. doi:10.1159/000055936. PubMed: 11493759.
[50]  Ho YS, Gargano M, Cao J, Bronson RT, Heimler I et al. (1998) Reduced fertility in female mice lacking copper-zinc superoxide dismutase. J Biol Chem 273: 7765-7769. doi:10.1074/jbc.273.13.7765. PubMed: 9516486.
[51]  Lee HJ, Jeong SK, Na K, Lee MJ, Lee SH et al. (2013) Comprehensive genome-wide proteomic analysis of human placental tissue for the chromosome-centric human proteome project. J Proteome Res 12: 2458-2466. doi:10.1021/pr301040g. PubMed: 23362793.
[52]  Vredendaal PJ, van den Berg IE, Malingré HE, Stroobants AK, Olde Weghuis DE et al. (1996) Human short-chain L-3-hydroxyacyl-CoA dehydrogenase: cloning and characterization of the coding sequence. Biochem Biophys Res Commun 223: 718-723. doi:10.1006/bbrc.1996.0961. PubMed: 8687463.
[53]  Saito S, Shiozaki A, Nakashima A, Sakai M, Sasaki Y (2007) The role of the immune system in preeclampsia. Mol Aspects Med 28: 192-209. doi:10.1016/j.mam.2007.02.006. PubMed: 17433431.
[54]  Zhang Z, Gao Y, Zhang L, Jia L, Wang P et al. (2013) Alterations of IL-6, IL-6R and gp130 in early and late onset severe preeclampsia. Hypertens Pregnancy, 32: 270–80. doi:10.3109/10641955.2013.798332. PubMed: 23782174.
[55]  Amburgey OA, Ing E, Badger GJ, Bernstein IM (2009) Maternal hemoglobin concentration and its association with birth weight in newborns of mothers with preeclampsia. J Matern Fetal Neonatal Med 22: 740-744. doi:10.3109/14767050902926947. PubMed: 19557662.
[56]  Ji L, Brki? J, Liu M, Fu G, Peng C et al. (2012) Placental trophoblast cell differentiation: Physiological regulation and pathological relevance to preeclampsia. Mol Aspects Med, 34: 981–1023. doi:10.1016/j.mam.2012.12.008. PubMed: 23276825.
[57]  Hsu JL, Huang SY, Chow NH, Chen SH (2003) Stable-isotope dimethyl labeling for quantitative proteomics. Anal Chem 75: 6843-6852. doi:10.1021/ac0348625. PubMed: 14670044.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133